compound semaglutide being discontinued Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Makers of compounded Wegovy, Ozempic

Clinical data shows a big difference in average weight loss between the two options

Most patients reach metabolic stability by 812 weeks, when donor screening labs typically normalize and collection centers are more likely to approve donation

(5) In the management of diabetes (including newly diagnosed type 2 diabetes), insulin therapy should be initiated as early as possible if there is significant unexplained weight loss[1]

Youre on your own for the lifestyle side of weight loss

A new study published in the New England Journal of Medicine comparing Eli Lillys Zepbound to Novo Nordisks Wegovy both approved to treat obesity found that Zepbound is more effective for weight loss

Outcomes vary by individual, and no specific results are guaranteed